{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:54:57Z","timestamp":1791262497063,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22178254"],"award-info":[{"award-number":["22178254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110401","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:16:51Z","timestamp":1787923011000},"page":"110401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and synthesis of tenofovir monophenyl ester phosphonoamidate prodrugs with improved anti-hepatitis B virus activity and intrahepatic tenofovir enrichment"],"prefix":"10.1016","volume":"182","author":[{"given":"Xiaolei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songgu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110401_bb0005","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110401_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00046-19","article-title":"HepatitisB virus: advances in prevention, diagnosis and therapy","volume":"33","author":"Nguyen","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110401_bb0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.16.4.569-596.2003","article-title":"Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infection","volume":"16","author":"De Clercq","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110401_bb0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1124\/jpet.117.243139","article-title":"Factors contributing to the antiviral effectiveness of Tenofovir","volume":"363","author":"Murphy","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2026.110401_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/2325958220919231","article-title":"A review and clinical understanding of tenofovir: Tenofovir disoproxil fumarate versus tenofovir alafenamide","volume":"19","author":"Wassner","year":"2020","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"10.1016\/j.bioorg.2026.110401_bb0035","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","article-title":"The ProTide prodrug technology: from the concept to the clinic","volume":"61","author":"Mehellou","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110401_bb0040","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.xphs.2016.12.003","article-title":"Development of a novel formulation that improves preclinical bioavailability of tenofovir disoproxil fumarate","volume":"106","author":"Watkins","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110401_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117607","article-title":"Development of tenofovir monobenzyl ester phosphonoamidate prodrugs with improved anti-hepatitis B virus activity and intrahepatic tenofovir enrichment","volume":"99","author":"Sun","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110401_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0026-895X(25)09957-2","article-title":"Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2\u2032,3\u2032-dideoxyuridine-5\u2032-triphosphate","volume":"37","author":"Hao","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110401_bb0055","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110401_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.04.015","article-title":"Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)","volume":"119","author":"Clercq","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110401_bb0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/182421a0","article-title":"Chemical aspects of selective toxicity","volume":"182","author":"Albert","year":"1958","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110401_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110401_bb0075","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrd.2018.46","article-title":"The expanding role of prodrugs in contemporary drug design and development","volume":"17","author":"Rautio","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110401_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.932934","article-title":"Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110401_bb0085","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/jac\/dkt532","article-title":"Phase I\/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults","volume":"69","author":"Markowitz","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2026.110401_bb0090","doi-asserted-by":"crossref","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","article-title":"Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977","volume":"285","author":"Murakami","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110401_bb0095","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/acs.jmedchem.5b01807","article-title":"Discovery of an orally active and liver-targeted prodrug of 5-fluoro-2\u2032-deoxyuridine for the treatment of hepatocellular carcinoma","volume":"59","author":"Peng","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110401_bb0100","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/jm9507338","article-title":"Decomposition pathways and in vitro HIV inhibitory effects of isoddA pronucleotides: toward a rational approach for intracellular delivery of nucleoside 5\u2032-monophosphates","volume":"39","author":"Valette","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110401_bb0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/074823378700300407","article-title":"Summary review of the health effects associated with phenol","volume":"3","author":"Bruce","year":"1987","journal-title":"Toxicol. Ind. Health"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110401_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/QAI.0b013e3182965d45","article-title":"Antiviral activity, safety, and pharmacokinetics\/pharmacodynamics of tenovir alafenamide as 10-day monotherapy in HIV-1-positive adults","volume":"63","author":"Ruane","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.bioorg.2026.110401_bb0115","series-title":"Double-liver-targeting phosphonoamidate and phosphonoamidate prodrugs. U.S. Patent US9156874B2","author":"Chang","year":"2015"},{"key":"10.1016\/j.bioorg.2026.110401_bb0120","doi-asserted-by":"crossref","first-page":"9493","DOI":"10.1021\/acs.jmedchem.2c00869","article-title":"An O-benzyl phosphonamidate prodrug of tenofovir for the treatment of hepatitis B virus infection","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110401_bb0125","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cmdc.201600156","article-title":"The ProTides boom","volume":"11","author":"Mehellou","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110401_bb0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1021\/acsmedchemlett.9b00184","article-title":"Design, synthesis, and anti-HBV activity of new Bis(L-amino acid)Ester Tenofovir prodrugs","volume":"10","author":"Wang","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110401_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/10915810152630729","article-title":"Final report on the safety assessment of benzyl alcohol, benzoic acid, and sodium benzoate","volume":"20","author":"Nair","year":"2001","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110401_bb0140","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1021\/op1001337","article-title":"Process improvements for the manufacture of Tenofovir disoproxil fumarate at commercial scale","volume":"14","author":"Ripin","year":"2010","journal-title":"Org. Process Res. Dev."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110401_bb0145","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1021\/acs.jmedchem.7b00734","article-title":"The ProTide prodrug technology: from the concept to the clinic","volume":"61","author":"Mehellou","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110401_bb0150","series-title":"Preparation method of tenofovir alafenamide. China","author":"Yuan","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110401_bb0155","series-title":"Novel tenofovir prodrug purifying method. China. Patent CN201710691626A 2017-08-14","author":"Chen","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110401_bb0160","series-title":"Tenofovir prodrug and pharmaceutical uses thereof. US. Patent US9908908B2 2018-03-06.","author":"Zhang","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110401_bb0165","series-title":"Preparation method of monophenyltenofovir. China. Patent CN202410098689.X 2024-07-23","author":"Wang","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110401_bb0170","series-title":"Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same. US 20020119443 A1","author":"Becker","year":"2026"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110401_bb0175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/655681","article-title":"Systematic review and meta-analysis: Ranal safety of tenofovir disoproxil fumarate in HIV-infected patients","volume":"51","author":"Cooper","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110401_bb0185","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.49.5.1898-1906.2005","article-title":"Selective intracellular activation of novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue","volume":"49","author":"Lee","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110401_bb0190","series-title":"FDA Clinical Pharmacology and Biopharmaceutics Review for NDA 208,464 (Vemlidy\u00ae)","year":"2016"},{"key":"10.1016\/j.bioorg.2026.110401_bb0195","series-title":"ICH Topic S7B: The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human Pharmaceuticals","author":"ICH","year":"2005"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:29:20Z","timestamp":1791260960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S0045206826009375"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110401","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of tenofovir monophenyl ester phosphonoamidate prodrugs with improved anti-hepatitis B virus activity and intrahepatic tenofovir enrichment","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110401"}}